Isovue is a contrast dye used in X-ray and CT imaging to make blood vessels, organs, and tissues visible on scans. Its active ingredient, iopamidol, contains iodine, which absorbs X-rays and causes the structures it flows through to appear bright and detailed on the resulting images. It is one of the most commonly used iodinated contrast agents in radiology departments.
How Isovue Works
When Isovue is injected into a blood vessel, it fills that vessel and every branch downstream, making the entire network visible on X-ray or CT. The iodine in the solution is what does the work: it absorbs X-ray energy much more effectively than surrounding soft tissue, creating sharp contrast between blood-filled structures and everything around them.
In CT scans of the brain, Isovue stays inside blood vessels because a protective barrier normally prevents substances from leaking into brain tissue. When that barrier is disrupted, as it often is by a tumor, the contrast dye seeps into the abnormal area and highlights it on the scan. In the rest of the body, the dye diffuses more freely out of blood vessels and into surrounding tissue. Tumors and inflamed areas absorb it differently than healthy tissue, which is what makes them stand out.
Specific Imaging Procedures
Isovue is FDA-approved for a wide range of diagnostic imaging in both adults and children. The procedures fall into three categories based on how the contrast is delivered.
Injected Into an Artery
When injected directly into an artery, Isovue is used for imaging blood vessels in the brain (cerebral arteriography), the arms and legs (peripheral arteriography), and the abdominal organs and aorta (visceral arteriography and aortography). It’s also used during coronary arteriography, where it flows through the heart’s arteries to reveal blockages or narrowing, and during ventriculography, which evaluates how well the heart chambers are pumping. In children, it’s approved for angiocardiography to assess heart structure and blood flow.
Injected Into a Vein
Intravenous Isovue is used for contrast-enhanced CT scans of the head and body in both adults and children. This is probably the most common way people encounter the drug. It’s also used for excretory urography, an imaging study of the kidneys and urinary tract, and for peripheral venography, which maps veins in the limbs to look for blood clots or other problems.
Taken by Mouth
When swallowed, Isovue coats the inside of the gastrointestinal tract so it shows up clearly on CT scans of the abdomen and pelvis. This oral use is approved for both adults and children.
Isovue-M: A Separate Product for Spinal Imaging
A related but distinct product called Isovue-M is specifically formulated for injection into the spinal canal. It is used for myelography, which images the spinal cord and nerve roots, as well as for CT cisternography and ventriculography of the brain’s fluid-filled spaces. Isovue-M is approved for lumbar, thoracic, cervical, and full-column myelography in adults, and for thoracic and lumbar myelography in children over age two.
This distinction matters because standard Isovue (the non-M versions) must never be injected into the spinal canal. Accidental spinal injection of standard Isovue can cause seizures, coma, brain hemorrhage, paralysis, and death. The two products are not interchangeable.
Different Concentrations for Different Scans
Isovue comes in four concentrations, each named for its iodine content per milliliter: Isovue-200, Isovue-250, Isovue-300, and Isovue-370. Higher iodine concentrations produce stronger contrast on images, so the choice depends on what’s being imaged.
- Isovue-370 (highest concentration): Used for coronary arteriography, heart chamber imaging, aortography, visceral arteriography, and pediatric heart imaging, where maximum contrast is needed.
- Isovue-300: Standard for brain and peripheral artery imaging.
- Isovue-250 and Isovue-300: Both options for CT scans and urography in adults and children.
- Isovue-200 (lowest concentration): Used for vein imaging in the limbs.
Common Side Effects
Most people tolerate Isovue well. In clinical studies, the most frequently reported reactions were mild: pain at the injection site (2.8%), hot flashes (1.5%), a burning sensation (1.4%), nausea (1.2%), and a feeling of warmth (1.1%). The warmth and flushing are a normal response to contrast dye entering the bloodstream and typically pass within a minute or two.
Less common reactions occurring in under 1% of patients include headache, vomiting, a metallic taste, skin rash, hives, itching, and temporary changes in heart rate or blood pressure. Some people feel lightheaded or notice brief visual changes.
Serious Reactions
Rare but serious allergic reactions (anaphylaxis) have been reported after Isovue injection. These can involve throat tightening, facial swelling, difficulty breathing, and a dangerous drop in blood pressure. Other rare postmarketing reports include seizures, loss of consciousness, cardiac arrest, and severe skin reactions. These events are uncommon but are the reason contrast-enhanced imaging is performed in a medical facility where emergency treatment is immediately available.
People with a history of allergic reactions to iodinated contrast dyes, asthma, or significant allergies are at higher risk. If you’ve had a reaction to contrast dye in the past, let your imaging team know beforehand.
Kidney Health and Hydration
Iodinated contrast agents like Isovue are filtered out of the body by the kidneys, and in some patients they can temporarily reduce kidney function, a condition known as contrast-induced kidney injury. People with existing kidney disease, diabetes, or advanced vascular disease face a higher risk.
Staying well hydrated before and after the procedure is one of the most important protective steps. In fact, intentional fasting from fluids before a contrast scan is considered dangerous because dehydration raises the risk of kidney problems. Clinical guidelines recommend using the lowest effective volume of contrast and avoiding repeat contrast exposure until kidney function has fully recovered.
What to Tell Your Care Team Beforehand
Before receiving Isovue, you should let your care team know if you have diabetes, kidney disease, sickle cell disease, a thyroid disorder, or a tumor called pheochromocytoma. A history of multiple myeloma is also relevant because it can affect how your kidneys handle the contrast. Mention any medications you’re taking, including over-the-counter drugs, and any previous reactions to contrast dyes, iodine, or other allergens.